Akebia to host conference call on March 9 at 8:30 a.m. ET Receives positive CHMP opinion for Vafseo™ (vadadustat); anticipates potential Marketing Authorization in Europe in May 2023 Reports Auryxia® (ferric citrate) net product revenue of $177.1M for 2022, an increase of approximately 24….